Cohen, C <br/><br/>
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Jul 2003 
 - 407-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Standard No.: </label>10.1124/jpet.103.049262  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Azepines--therapeutic use<br/>Behavior, Animal--drug effects<br/>Body Temperature--drug effects<br/>Brain--metabolism<br/>Cardiovascular System--drug effects<br/>Cells, Cultured<br/>Dextroamphetamine--pharmacology<br/>Discrimination Learning<br/>Drug Interactions<br/>Heterocyclic Compounds, 4 or More Rings--therapeutic use<br/>Humans<br/>Male<br/>Mecamylamine--pharmacology<br/>Microdialysis<br/>Motor Activity--drug effects<br/>Nicotine--pharmacology<br/>Nicotinic Agonists--therapeutic use<br/>Oocytes--drug effects<br/>Radioligand Assay<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Nicotinic--drug effects<br/>Self Administration<br/>Smoking--drug therapy<br/>Smoking Cessation<br/>Substance Withdrawal Syndrome<br/>Transfection<br/>Xenopus laevis